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molecules, which then act in competition for the activation sites of 
the operbns or regulons under quorum sensing control. Control of 
pathogenicity in this way may offer a unique form of antimicrobial 
therapy without the endotoxemia associated with Gram-negative cell 
lysis. 
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Introduction and  objectives: We previously reported that bacteria 
communicate with each other by using growth-regulating sonic/ 
ultrasonic signals (Matsuhashi et al, J Gen Appl Microbiol 1996; 42: 
315-323). Barillus subtilis cells emit sounds at frequencies ofabout 8.5 
kHz and its overtones, and the growth of B. carboniphilus cells is 
promoted by sounds/ultrasounds from a speaker at similar frequencies 
under non-permissive stress conditions (Matsuhashi et al, J Gen Appl 
Microbiol 1998; 44: 49-55). Graphite, charcoal and other materials 
convert external energy, such as pulses of infrared light, into sonic 
signals (Matsuhashi et al, J Gen Appl Microbiol 1997; 43: 225-230). 
The response of bacteria to sounds may be utilized in antibiotic 
therapy. 
Results: (1) Soft solid matter, such as solidified agar in growth 
media, can significantly promote or inhibit the growth of bacteria 
and yeast under stress conditions and the hatching of fish eggs. The 
effect is probably due to photo-acoustic emission resulting from the 
conversion of external electromagnetic energy and can be diminished 
by shielding the agar and organisms with aluminum foil. E. coli and 
yeasts also responded to signals from the agar. This mechanism 
probably explains why many bacteria and mycoplasmas grow well on 
soft solid surfaces such as animal tissue. (2) In contrast to B. 
carboniphilus, soft low-frequency sounds from a speaker, at frequencies 
between 10 and 800 Hz, markedly inhibit the growth of E. coli. This 
E. coli behavior, which may be common in related Gram-negative 
bacilli, suggests that low-frequency sounds may help to overcome 
infections by Gram-negative bacteria. 
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There are two broad strategies for controlling bacterial infection: 
either (1) kill the organism or (2) attenuate virulence such that the 
infecting oragnism fails to adapt to the host environment and can be 
cleared by the innate host defenses. The latter approach has, until 
recently, lacked specific targets for rational drug design. However, the 
discovery that bacterial cells communicate with each other using 
small diffusible signaling molecules to regulate virulence in concert 
with cell population density (termed quorum sensing) now offers 
such a novel target. 
Many Gram-negative bacteria employ N-acylhomoserine lactones 
(AHLs) as quorum sensing signaling molecules which not only 
control gene expression but also possess potent pharmacologic 
activities such that they may function as virulence determinants per 
se. Understanding the molecular mechanisms by which AHLs are 
produced (usually via a member of the Lux family of AHL synthases) 
and by which AHLs activate target gene expression (via members of 
thr LuxR family of transcriptional regulators) is central to the design 
of small-molecule antagonists (Quorum Sensing Blockers, QSBs) 
capable of attenuating virulence through the blockade of either signal 
generation or signal transduction. 
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This presentation reviews the incidence, clinical manifestations, 
differential diagnosis, risk factors and pathogenesis of allergic 
reactions of two important classes of antimicrobials; beta-lactams and 
sulfonamides. The diagnostic work-up of a patient with a history of 
an allergic reaction will be discussed, as well as the possibility of the 
safe administration of the drug in the face of an allergy using 
immunotherapy Emerging concepts of beta-lactam side-chain 
allergy, the role of cellular immune mechanisms and the clinical 
importance of cross-reactivity of allergic reactions to different classes 
of beta-lactams will be emphasized. 
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Several groups of antimicrobial agents have the potential to have 
adverse effects on the musculoskeletal system. At the beginning of 
the 1960s, the effects of tetracycline on the developing skeleton were 
investigated in premature infants by multiple X-ray examinations. 
Based on these results, tetracylines were considered to be contra- 
indicated in infants and children. Quinolones are another group of 
frequently used drugs that have toxic effects on connective tissue 
structures. Due to their cartilage toxicity-as shown in immature 
dogs and other animals-they are contraindicated in children and 
adolescents. Human experience with pefloxacin in children showed 
an unacceptably high incidence of joint toxicity (10%). However, 
with nalidixic acid, norfloxacin and ciprofloxacin, favorable clinical 
results in juvenile patients have been published. Also, quinolones have 
the potential to induce tendon disorders (tendinitis, Achilles tendon 
rupture) which have occurred mainly in elderly patients. Mechanistic 
studies from our group indicate that the magnesium-chelating 
properties of the quinolones might be responsible for these toxic 
effects. Less often used antimicrobial drugs which might affect the 
musculoskeletal system include, for example, pyrazinamide, rifabutin, 
and quinupristin-dalfopristin. 
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Central and eastern European countries face the same types of 
